Top 10 Common Findings Detected During Cannabis Laboratory Assessments: A Guide to Assist with Accreditation

With the cannabis industry growing rapidly, laboratories are adapting to the new market demand for medical cannabis testing in accordance to ISO/IEC 17025. Third-party accreditation bodies, such as Perry Johnson Laboratory Accreditation, Inc. (PJLA), conduct these assessments to determine that laboratories are following relevant medical cannabis testing standard protocols in order to detect potency and contaminant levels in cannabis. Additionally, laboratories are required to implement and maintain a quality management system throughout their facility. Obtaining accreditation is a challenge for laboratories initially going through the process. There are many requirements outlined in the standard that laboratories must adhere to in order to obtain a final certificate of accreditation. Laboratories should evaluate the ISO 17025 standard thoroughly, receive adequate training, implement the standard within their facility and conduct an internal audit in order to prepare for a third-party assessment. Being prepared will ultimately reduce the number of findings detected during the on-site assessment. Listed below is research and evidence gathered by PJLA to determine the top ten findings by clause specifically in relation to cannabis testing laboratories.

The top 10 findings by clause

4.2: Management System

4.3: Document Control

4.6: Purchasing Services and Supplies

4.13: Control of Records

4.14: Internal Audits

5.2: Personnel

5.4: Test and Calibration Methods and Method Validation

5.6: Measurement Traceability

5.10: Reporting the Results

SOP-3: Use of the Logo

About The Author

Exit mobile version